Is Synlogic Inc (SYBX) the Top Pick in the Biotechnology Industry? – InvestorsObserver

Synlogic Inc (SYBX) is around the middle of the Biotechnology industry according to InvestorsObserver. SYBX received an overall rating of 42, which means that it scores higher than 42 percent of all stocks. Synlogic Inc also achieved a score of 34 in the Biotechnology industry, putting it above 34 percent of Biotechnology stocks. Biotechnology is ranked 18 out of the 148 industries.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 42 means the stock is more attractive than 42 percent of stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Synlogic Inc (SYBX) stock is down -0.78% while the S&P 500 is unchanged 0% as of 11:39 AM on Tuesday, Aug 18. SYBX has fallen -$0.02 from the previous closing price of $2.57 on volume of 57,969 shares. Over the past year the S&P 500 is higher by 15.68% while SYBX has fallen -47.20%. SYBX lost -$1.67 per share the over the last 12 months.

To see the top 5 stocks in Biotechnology click here.

Go here to see the original:
Is Synlogic Inc (SYBX) the Top Pick in the Biotechnology Industry? - InvestorsObserver